Clinical Trial

Evaluation of Nucleotide-Binding Oligomerization Domain-Containing Protein (NOD) 1 and NOD 2

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated March 12, 2026 completion). Its status may not reflect the trial's current state.
Summary
The host immune response to microorganisms is primarily recognized by pattern recognition receptors (PRRs), including toll-like receptors and nucleotide-binding oligomeric domain (NOD) receptors (NLRs). The aim of this study was to examine the relationship between periodontal disease and NOD in serum and saliva samples.
Trial Details
NCT Number NCT07160894
Lead Sponsor Medipol University
Conditions Periodontal Diseases Inflammation
Enrollment 75 participants
Start Date 2025-09-15
Primary Completion 2026-03-12 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2025-09-08